Meet-URO 12

A Phase II, Randomized, Trial of Niraparib Versus Best Supportive Care as Maintenance Treatment In Patients With Locally Advanced Or Metastatic Urothelial Cancer Whose Disease Did Not Progress After Completion Of First-line Platinum-containing Chemotherapy

Stato

Studio in corso - Arruolamento in corso

Patologia

Urotelio

Tipologia

Prospettico

Centro Coordinatore: Università di Torino Ospedale Mauriziano Umberto I - Torino
Principal Investigator: Massimo Di Maio
Sub Investigator: -
Study Coordinator: -

Documentazione disponibile